<DOC>
	<DOCNO>NCT00446485</DOCNO>
	<brief_summary>The purpose study determine weather Ginkgo biloba standardize extract ( 24 % ginkoflavonoglicozides 6 % terpene ) effective treatment cognitive concentration impairment</brief_summary>
	<brief_title>Efficacy Safety Ginkgo Biloba Extract Mild Cognitive Impairment Cerebrovascular Insufficiency</brief_title>
	<detailed_description>Inclusion criterion cerebrovascular insufficiency MNSE &gt; 20 . 90 patient divide three group randomly . First group administer 120 mg ginkgo biloba extract , second group 60 mg extract third group administer placebo period 6 month . Methods use evaluation SCAG , MMSE , MDRS , VFT , CGI , TCD color Doppler carotid artery . Methods use follow safety include : routine blood test , biochemical test , neurologic physical examination , vital sign ECG .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<criteria>cerebrovascular insufficiency mild cognitive disorder ( MMSE=2028 ) pregnancy cognitive disorder cause psychological , metabolic endocrine nutritional heart disorder alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>ginkgo biloba</keyword>
	<keyword>cerebrovascular insufficiency</keyword>
	<keyword>mild cognitive impairment</keyword>
	<keyword>concentration impairment</keyword>
</DOC>